About the Cancer Vaccines & Oncolytic Therapies Session
Cancer vaccines and oncolytic therapies represent rapidly developing approaches designed to stimulate or enhance antitumor immune responses. This session examines preventive and therapeutic vaccine platforms, tumor-specific antigens, personalized vaccination strategies, viral therapies, combination approaches, and clinical translation.
Abstract Scope and Participation
Submissions may cover neoantigen vaccines, RNA and DNA vaccines, peptide and protein vaccines, dendritic-cell vaccines, oncolytic viruses, vaccine delivery, immune monitoring, combination immunotherapy, and clinical development. Researchers, immunologists, oncologists, virologists, and biotechnology professionals are welcome.
Topics Covered in Cancer Vaccines & Oncolytic Therapies
Cancer Vaccines
Neoantigen Vaccines
RNA & DNA Vaccines
Dendritic Cell Vaccines
Oncolytic Viruses
Vaccine Immunotherapy
Related Scientific Sessions at CIOC 2027
Why Attend the Cancer Vaccines & Oncolytic Therapies Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cancer Vaccines & Oncolytic Therapies work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cancer Vaccines & Oncolytic Therapies research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cancer Vaccines & Oncolytic Therapies track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cancer Vaccines & Oncolytic Therapies Conference 2027 — FAQs
What is the Cancer Vaccines & Oncolytic Therapies track at CIOC 2027?
The Cancer Vaccines & Oncolytic Therapies track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cancer Vaccines & Oncolytic Therapies. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cancer Vaccines & Oncolytic Therapies sessions?
Cancer researchers and clinicians, educators and students with an interest in Cancer Vaccines & Oncolytic Therapies are all welcome — whether presenting or attending.
Can I present my research in the Cancer Vaccines & Oncolytic Therapies track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cancer Vaccines & Oncolytic Therapies sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cancer Vaccines & Oncolytic Therapies track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.